451 related articles for article (PubMed ID: 10865508)
21. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
22. [Analgesic effects of cyclooxygenase 2 inhibitors].
Jayr C
Bull Cancer; 2004 May; 91 Spec No():S125-31. PubMed ID: 15239341
[TBL] [Abstract][Full Text] [Related]
23. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
24. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
25. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
26. [Arthrosis drugs critically evaluated. Emphasis on cartilage protection].
Wepner U
MMW Fortschr Med; 2002 Mar; 144(13):4-8. PubMed ID: 12001589
[No Abstract] [Full Text] [Related]
27. COX-2-Selective NSAIDs: new and improved?
Lichtenstein DR; Wolfe MM
JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
[No Abstract] [Full Text] [Related]
28. COX-2 inhibitors and Celebrex: safe or suspect?
Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
[No Abstract] [Full Text] [Related]
29. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
[No Abstract] [Full Text] [Related]
30. COX-1 and COX-2 inhibition: current status and future perspective.
Greyn J; Lauwers MH; Vanlersberghe C; Camu F
Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
[No Abstract] [Full Text] [Related]
31. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
[No Abstract] [Full Text] [Related]
32. Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs?
Simon LS
Curr Opin Rheumatol; 2000 May; 12(3):163-70. PubMed ID: 10803743
[TBL] [Abstract][Full Text] [Related]
33. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
Wigand R
Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
[No Abstract] [Full Text] [Related]
34. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
35. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
36. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
van der Bijl P; van der Bijl P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
[TBL] [Abstract][Full Text] [Related]
37. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
Nasonova VA
Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
[No Abstract] [Full Text] [Related]
38. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease.
Willoughby DA; Moore AR; Colville-Nash PR
Lancet; 2000 Feb; 355(9204):646-8. PubMed ID: 10696997
[TBL] [Abstract][Full Text] [Related]
39. [Specific COX-2 inhibitors. Also effective in arthritis?].
Einecke D
MMW Fortschr Med; 2000 Jan; 142(3):10. PubMed ID: 10726454
[No Abstract] [Full Text] [Related]
40. COX-2 inhibitors.
Crowther CL
Lippincotts Prim Care Pract; 1999; 3(4):394-6. PubMed ID: 10624270
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
